Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $350.67 million. The enterprise value is $441.43 million.
Important Dates
The last earnings date was Tuesday, March 3, 2026, after market close.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 65.06 million shares outstanding. The number of shares has increased by 3.95% in one year.
| Current Share Class | 65.06M |
| Shares Outstanding | 65.06M |
| Shares Change (YoY) | +3.95% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 12.17% |
| Owned by Institutions (%) | 66.71% |
| Float | 49.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| Forward PS | 0.95 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90
| Current Ratio | 1.90 |
| Quick Ratio | 1.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -10.25% |
| Return on Invested Capital (ROIC) | -17.58% |
| Return on Capital Employed (ROCE) | -24.97% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | $903,271 |
| Profits Per Employee | -$156,964 |
| Employee Count | 329 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 5.12 |
Taxes
In the past 12 months, Evolus has paid $677,000 in taxes.
| Income Tax | 677,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.95% in the last 52 weeks. The beta is 1.01, so Evolus's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -62.95% |
| 50-Day Moving Average | 5.12 |
| 200-Day Moving Average | 7.09 |
| Relative Strength Index (RSI) | 58.33 |
| Average Volume (20 Days) | 1,392,188 |
Short Selling Information
The latest short interest is 7.80 million, so 11.99% of the outstanding shares have been sold short.
| Short Interest | 7.80M |
| Short Previous Month | 7.39M |
| Short % of Shares Out | 11.99% |
| Short % of Float | 15.86% |
| Short Ratio (days to cover) | 6.23 |
Income Statement
In the last 12 months, Evolus had revenue of $297.18 million and -$51.64 million in losses. Loss per share was -$0.80.
| Revenue | 297.18M |
| Gross Profit | 197.11M |
| Operating Income | -37.60M |
| Pretax Income | -50.96M |
| Net Income | -51.64M |
| EBITDA | -30.09M |
| EBIT | -37.60M |
| Loss Per Share | -$0.80 |
Full Income StatementBalance Sheet
The company has $53.83 million in cash and $155.00 million in debt, with a net cash position of -$101.17 million or -$1.56 per share.
| Cash & Cash Equivalents | 53.83M |
| Total Debt | 155.00M |
| Net Cash | -101.17M |
| Net Cash Per Share | -$1.56 |
| Equity (Book Value) | -23.11M |
| Book Value Per Share | -0.36 |
| Working Capital | 67.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$42.27 million and capital expenditures -$3.44 million, giving a free cash flow of -$45.71 million.
| Operating Cash Flow | -42.27M |
| Capital Expenditures | -3.44M |
| Free Cash Flow | -45.71M |
| FCF Per Share | -$0.70 |
Full Cash Flow StatementMargins
Gross margin is 66.33%, with operating and profit margins of -12.65% and -17.38%.
| Gross Margin | 66.33% |
| Operating Margin | -12.65% |
| Pretax Margin | -17.15% |
| Profit Margin | -17.38% |
| EBITDA Margin | -10.13% |
| EBIT Margin | -12.65% |
| FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.95% |
| Shareholder Yield | -3.95% |
| Earnings Yield | -15.18% |
| FCF Yield | -13.43% |
Analyst Forecast
The average price target for Evolus is $15.50, which is 187.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 187.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 17.06% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -1.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.52 |
| Piotroski F-Score | 2 |
